Cancer Research Cancer Medicine 8  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 6031, August 1, 2008. doi: 10.1158/0008-5472.CAN-07-6851
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matheu, A.
Right arrow Articles by Serrano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matheu, A.
Right arrow Articles by Serrano, M.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: DNA Damage and Stress Responses

Review Articles

The Arf/p53 Pathway in Cancer and Aging

Ander Matheu2, Antonio Maraver1 and Manuel Serrano1

1 Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain and 2 Division of Stem Cell Biology and Developmental Genetics, Medical Research Council National Institute for Medical Research, London, United Kingdom

Requests for reprints: Manuel Serrano, Spanish National Cancer Research Center (CNIO), 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain. Phone: 34-91-732-8000; Fax: 34-91-732-8028; E-mail: mserrano{at}cnio.es.

Key Words: aging • cancer • p53

Arf and p53 are regarded among the most relevant tumor suppressors based on their ubiquitous and frequent inactivation in human cancer. The Arf/p53 pathway protects cells against several types of damage and this is the basis of its tumor suppressor activity. Interestingly, aging is a process associated with the accumulation of damage derived from chronic stresses of small magnitude. In agreement with its damage protection role, it has been recently described that the Arf/p53 pathway not only protects mammalian organisms from cancer but also from aging. However, there is also evidence that p53, under certain circumstances, such as when constitutively active, can induce aging. We discuss here the current evidence linking the Arf/p53 pathway to the process of aging and present a unified model. [Cancer Res 2008;68(15):6031–4]




This article has been cited by other articles:


Home page
Cold Spring Harb. Perspect. Biol.Home page
L. A. Donehower
Using Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Cold Spring Harb Perspect Biol, December 1, 2009; 1(6): a001081 - a001081.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
K. Chobotova
Aging and Cancer: Converging Routes to Disease Prevention
Integr Cancer Ther, June 1, 2009; 8(2): 115 - 122.
[Abstract] [PDF]


Home page
Genes Dev.Home page
H. Chen, X. Gu, I-h. Su, R. Bottino, J. L. Contreras, A. Tarakhovsky, and S. K. Kim
Polycomb protein Ezh2 regulates pancreatic {beta}-cell Ink4a/Arf expression and regeneration in diabetes mellitus
Genes & Dev., April 15, 2009; 23(8): 975 - 985.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.